Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 77 followers
Latest posts
Last updated 1 day ago
EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab
1 day ago
It is a cancer medicine used to treat adult patients with multiple...
Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients with Advanced ROS1-positive NSCLC
2 days ago
Updated efficacy and safety results from the TRUST-I study
National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors
2 days ago
Hundreds of thousands of people diagnosed with cancer are still alive today...
EMA Recommends Extension of Indications for Dabrafenib and Trametinib
3 days ago
New indications concern the treatment of adolescents from 12 years of age...
Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC
4 days ago
Building the PREDICT_sTILs prognostication model
ESMO–ESTRO Joint Consensus Papers Address the Safety of Combining Radiotherapy with Targeted Cancer Therapies and Immunotherapy
4 days ago
Modern oncology represents a rapidly evolving and increasingly complex field, with a...
ESMO Stresses the Importance of Continuity of Cancer Clinical Trials (CT) During Public Health Emergencies (PHE) in Response to European Medicines Agency (EMA) Consultation
5 days ago
ESMO feedback to EMA public consultation on new guidance for the conduct...
Pesticide Usage, in Particular of Picloram, Associated with Early Onset Colorectal Cancer
5 days ago
Findings from an analysis of exposome traits based on epigenetic fingerprints
EMA Recommends Granting a Marketing Authorisation for Lurbinectedin
9 days ago
It is indicated for the maintenance treatment of adult patients with extensive-stage...
Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC
9 days ago
Findings from the Beamion LUNG-1 study
Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian
10 days ago
This guide is now available in 15 different languages
EMA Recommends Extension of Indications for Inotuzumab Ozogamicin
10 days ago
New indication concerns treatment of paediatric patients with CD22-positive B cell precursor...